Phase I trial of EBC C12 +/- EBS A42
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2011
At a glance
- Drugs Streptococcal B vaccine (Primary) ; EBS A42; EBS C12
- Indications Streptococcal infections
- Focus Adverse reactions
- Sponsors Emergent BioSolutions
- 01 Dec 2011 Status changed from planning to discontinued prior to enrolment (development of vaccine discontinued).
- 27 Dec 2006 The expected completion date for this trial is now 1 Dec 2008.
- 27 Dec 2006 New trial record.